Since the advent of robot-assisted surgery in the early 2000’s, this disruptive technology has revolutionized approaches to surgery across all specialties including gynecology where FDA approval was obtained in the spring of 2005. Although significant amounts of peer-reviewed data support the equivalency and at times superiority of robotics compared to the more conventional surgical routes, much debate over its use still exist in gynecology. A focus of much of this discussion in the USA has been around the issues of cost, training and a misguided understanding of value-based medicine. The following presentation will debunk myths surrounding the use of robotics in gynecologic surgery in the USA and in doing answer the question posed by elaborating on the truth of where we are with the robot.